May 15th 2025
Six winners and two honorable mentions were revealed at ISPE’s Europe Annual Conference in London.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Oxford Biomedica Signs Agreement with Vaccines Manufacturing and Innovation Centre
June 12th 2020Oxford Biomedica, has signed a collaboration agreement with the not-for-profit organization, the Vaccines Manufacturing and Innovation Centre, to provide the UK with its first strategic vaccine development and advanced manufacturing capability.